Variant report
Variant | rs2532343 |
---|---|
Chromosome Location | chr17:44344097-44344098 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:293)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr17:44344027-44344115 | K562 | blood: | n/a | n/a |
2 | TCF3 | chr17:44344041-44344255 | GM12878 | blood: | n/a | n/a |
3 | NRF1 | chr17:44343925-44344925 | SK-N-SH | brain: | n/a | chr17:44344455-44344469 chr17:44344458-44344469 |
4 | ZBTB7A | chr17:44344003-44344528 | K562 | blood: | n/a | chr17:44344114-44344123 |
5 | TAF1 | chr17:44343972-44344733 | PFSK-1 | brain: | n/a | n/a |
6 | POLR2A | chr17:44343602-44345112 | Hela-S3 | cervix: | n/a | n/a |
7 | HDAC2 | chr17:44343942-44344260 | HepG2 | liver: | n/a | n/a |
8 | HEY1 | chr17:44343325-44345041 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr17:44343461-44344975 | K562 | blood: | n/a | n/a |
10 | MYC | chr17:44343254-44344643 | H1-hESC | embryonic stem cell: | n/a | chr17:44343780-44343790 |
11 | POLR2A | chr17:44343979-44344285 | SK-N-SH | brain: | n/a | n/a |
12 | POLR2A | chr17:44343934-44344972 | K562 | blood: | n/a | n/a |
13 | POLR2A | chr17:44343579-44344994 | NB4 | blood: | n/a | n/a |
14 | ZBTB33 | chr17:44343936-44344682 | HCT-116 | colon: | n/a | n/a |
15 | POLR2A | chr17:44343914-44344726 | ECC-1 | luminal epithelium: | n/a | n/a |
16 | POLR2A | chr17:44343859-44344292 | GM12891 | blood: | n/a | n/a |
17 | PAX5 | chr17:44343963-44345361 | GM12878 | blood: | n/a | chr17:44344651-44344660 chr17:44344258-44344267 |
18 | MYC | chr17:44344014-44344384 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr17:44343607-44344841 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | ELF1 | chr17:44343955-44344950 | GM12878 | blood: | n/a | chr17:44344437-44344449 |
21 | TBP | chr17:44343613-44345010 | K562 | blood: | n/a | n/a |
22 | POLR2A | chr17:44343448-44344875 | HUVEC | blood vessel: | n/a | n/a |
23 | E2F4 | chr17:44344018-44345204 | MCF10A-Er-Src | breast: | n/a | chr17:44344508-44344515 chr17:44344459-44344468 chr17:44344508-44344515 chr17:44344508-44344515 chr17:44344255-44344269 |
24 | POLR2A | chr17:44343922-44344342 | GM12891 | blood: | n/a | n/a |
25 | TAF1 | chr17:44344009-44344745 | ECC-1 | luminal epithelium: | n/a | n/a |
26 | BRCA1 | chr17:44344000-44344115 | Hela-S3 | cervix: | n/a | n/a |
27 | MAX | chr17:44343723-44345055 | Hela-S3 | cervix: | n/a | chr17:44343780-44343790 |
28 | GTF2F1 | chr17:44344064-44344641 | K562 | blood: | n/a | n/a |
29 | MTA3 | chr17:44343477-44344229 | GM12878 | blood: | n/a | n/a |
30 | NFIC | chr17:44343753-44344289 | GM12878 | blood: | n/a | n/a |
31 | SMARCB1 | chr17:44343601-44345331 | Hela-S3 | cervix: | n/a | n/a |
32 | TBP | chr17:44343761-44344921 | HepG2 | liver: | n/a | n/a |
33 | EGR1 | chr17:44344029-44344455 | GM12878 | blood: | n/a | chr17:44344112-44344122 chr17:44344110-44344123 |
34 | POLR2A | chr17:44343944-44344642 | HCT-116 | colon: | n/a | n/a |
35 | POLR2A | chr17:44343662-44344898 | HL-60 | blood: | n/a | n/a |
36 | MAX | chr17:44344036-44344316 | MCF-7 | breast: | n/a | n/a |
37 | E2F6 | chr17:44343573-44344965 | K562 | blood: | n/a | chr17:44344508-44344515 chr17:44344459-44344468 chr17:44344508-44344515 chr17:44344508-44344515 chr17:44344255-44344269 |
38 | UBTF | chr17:44344014-44344981 | K562 | blood: | n/a | n/a |
39 | SIN3AK20 | chr17:44343588-44344253 | H1-hESC | embryonic stem cell: | n/a | n/a |
40 | MTA3 | chr17:44343310-44345297 | GM12878 | blood: | n/a | n/a |
41 | MAX | chr17:44344006-44344870 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | POLR2A | chr17:44343498-44345220 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | POLR2A | chr17:44343950-44344902 | A549 | lung: | n/a | n/a |
44 | FOXM1 | chr17:44343828-44345290 | GM12878 | blood: | n/a | n/a |
45 | PML | chr17:44343799-44344755 | K562 | blood: | n/a | chr17:44343933-44343941 |
46 | TAF1 | chr17:44343933-44344699 | GM12878 | blood: | n/a | n/a |
47 | MAX | chr17:44343959-44344823 | ECC-1 | luminal epithelium: | n/a | n/a |
48 | POLR2A | chr17:44344016-44344247 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | POLR2A | chr17:44343631-44344677 | HEK293 | kidney: | n/a | n/a |
50 | POLR2A | chr17:44343911-44344790 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:43661202..43663303-chr17:44342809..44346012,4 | K562 | blood: | |
2 | chr17:44268998..44273525-chr17:44341673..44346026,7 | K562 | blood: | |
3 | chr17:44268896..44271237-chr17:44343151..44346281,5 | K562 | blood: | |
4 | chr17:44343915..44344828-chr17:61043375..61044215,2 | Hela-S3 | cervix: | |
5 | chr1:154946305..154946945-chr17:44343963..44344653,2 | Hela-S3 | cervix: | |
6 | chr17:44343791..44344569-chr6:32939576..32940529,2 | Hela-S3 | cervix: | |
7 | chr17:44343769..44344373-chr19:48103090..48103773,2 | Hela-S3 | cervix: | |
8 | chr14:67707799..67708365-chr17:44343216..44344160,2 | Hela-S3 | cervix: | |
9 | chr17:43661803..43664232-chr17:44342561..44344320,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261575 | TF binding region |
ENSG00000263931 | Chromatin interaction |
ENSG00000264070 | Chromatin interaction |
ENSG00000160691 | Chromatin interaction |
ENSG00000214401 | Chromatin interaction |
ENSG00000072415 | Chromatin interaction |
ENSG00000204256 | Chromatin interaction |
ENSG00000120071 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10221243 | 1.00[ASN][1000 genomes] |
rs10514901 | 1.00[ASN][1000 genomes] |
rs10514903 | 1.00[ASN][1000 genomes] |
rs10514904 | 1.00[ASN][1000 genomes] |
rs11079733 | 1.00[ASN][1000 genomes] |
rs1122380 | 1.00[ASN][1000 genomes] |
rs1122381 | 1.00[ASN][1000 genomes] |
rs12150087 | 1.00[ASN][1000 genomes] |
rs12150319 | 1.00[ASN][1000 genomes] |
rs1358439 | 1.00[ASN][1000 genomes] |
rs1468240 | 1.00[ASN][1000 genomes] |
rs1476554 | 1.00[ASN][1000 genomes] |
rs16940904 | 1.00[ASN][1000 genomes] |
rs1706725 | 0.81[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17576165 | 1.00[ASN][1000 genomes] |
rs17576200 | 1.00[ASN][1000 genomes] |
rs17576631 | 1.00[ASN][1000 genomes] |
rs17576695 | 1.00[ASN][1000 genomes] |
rs17576709 | 1.00[ASN][1000 genomes] |
rs17576779 | 1.00[ASN][1000 genomes] |
rs17576842 | 1.00[ASN][1000 genomes] |
rs17576870 | 1.00[ASN][1000 genomes] |
rs17576954 | 1.00[ASN][1000 genomes] |
rs17576989 | 1.00[ASN][1000 genomes] |
rs17577024 | 1.00[ASN][1000 genomes] |
rs17577052 | 1.00[ASN][1000 genomes] |
rs17577159 | 1.00[ASN][1000 genomes] |
rs17577313 | 1.00[ASN][1000 genomes] |
rs17577369 | 1.00[ASN][1000 genomes] |
rs17577447 | 1.00[ASN][1000 genomes] |
rs17577496 | 1.00[ASN][1000 genomes] |
rs17577650 | 1.00[ASN][1000 genomes] |
rs17577877 | 1.00[ASN][1000 genomes] |
rs17577954 | 1.00[ASN][1000 genomes] |
rs17577975 | 1.00[ASN][1000 genomes] |
rs17659881 | 1.00[ASN][1000 genomes] |
rs17659953 | 1.00[ASN][1000 genomes] |
rs17660017 | 1.00[ASN][1000 genomes] |
rs17660065 | 1.00[ASN][1000 genomes] |
rs17660132 | 1.00[ASN][1000 genomes] |
rs17660167 | 1.00[ASN][1000 genomes] |
rs17660228 | 1.00[ASN][1000 genomes] |
rs17660251 | 1.00[ASN][1000 genomes] |
rs17660294 | 1.00[ASN][1000 genomes] |
rs17660337 | 1.00[ASN][1000 genomes] |
rs17660398 | 1.00[ASN][1000 genomes] |
rs17660464 | 1.00[ASN][1000 genomes] |
rs17660488 | 1.00[ASN][1000 genomes] |
rs17660595 | 1.00[ASN][1000 genomes] |
rs17660847 | 1.00[ASN][1000 genomes] |
rs17660865 | 1.00[ASN][1000 genomes] |
rs17660907 | 1.00[ASN][1000 genomes] |
rs17660936 | 1.00[ASN][1000 genomes] |
rs17661015 | 1.00[ASN][1000 genomes] |
rs17661027 | 1.00[ASN][1000 genomes] |
rs17661045 | 1.00[ASN][1000 genomes] |
rs17661141 | 1.00[ASN][1000 genomes] |
rs17661348 | 1.00[ASN][1000 genomes] |
rs17661385 | 1.00[ASN][1000 genomes] |
rs17661428 | 1.00[ASN][1000 genomes] |
rs17664048 | 1.00[ASN][1000 genomes] |
rs17665188 | 0.91[AFR][1000 genomes];0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1819040 | 1.00[ASN][1000 genomes] |
rs1918786 | 1.00[ASN][1000 genomes] |
rs1918787 | 1.00[ASN][1000 genomes] |
rs1918794 | 1.00[ASN][1000 genomes] |
rs1966345 | 1.00[ASN][1000 genomes] |
rs2066899 | 1.00[ASN][1000 genomes] |
rs2097760 | 1.00[ASN][1000 genomes] |
rs2141298 | 1.00[ASN][1000 genomes] |
rs2243967 | 0.87[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2261016 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2262140 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2262144 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2264542 | 1.00[ASN][1000 genomes] |
rs2316954 | 1.00[ASN][1000 genomes] |
rs2316955 | 1.00[ASN][1000 genomes] |
rs2316956 | 1.00[ASN][1000 genomes] |
rs2429438 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2429440 | 0.86[AMR][1000 genomes];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2429442 | 1.00[ASN][1000 genomes] |
rs2458216 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2458217 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2458218 | 1.00[ASN][1000 genomes] |
rs2463515 | 1.00[ASN][1000 genomes] |
rs2469914 | 1.00[ASN][1000 genomes] |
rs2469940 | 0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2469941 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2469943 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2469944 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532229 | 1.00[ASN][1000 genomes] |
rs2532233 | 1.00[ASN][1000 genomes] |
rs2532239 | 1.00[ASN][1000 genomes] |
rs2532244 | 1.00[ASN][1000 genomes] |
rs2532276 | 1.00[ASN][1000 genomes] |
rs2532277 | 1.00[ASN][1000 genomes] |
rs2532307 | 1.00[ASN][1000 genomes] |
rs2532329 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532330 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532331 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532336 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532339 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532340 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532349 | 0.82[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532363 | 0.86[AMR][1000 genomes];0.81[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2532411 | 1.00[ASN][1000 genomes] |
rs2532412 | 1.00[ASN][1000 genomes] |
rs2532414 | 1.00[ASN][1000 genomes] |
rs2532416 | 1.00[ASN][1000 genomes] |
rs2532417 | 1.00[ASN][1000 genomes] |
rs2532418 | 1.00[ASN][1000 genomes] |
rs2532419 | 1.00[ASN][1000 genomes] |
rs2532423 | 1.00[ASN][1000 genomes] |
rs2668611 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668614 | 1.00[ASN][1000 genomes] |
rs2668622 | 0.88[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668626 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668627 | 0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668645 | 1.00[ASN][1000 genomes] |
rs2668653 | 1.00[ASN][1000 genomes] |
rs2668658 | 1.00[ASN][1000 genomes] |
rs2668662 | 1.00[ASN][1000 genomes] |
rs2668665 | 1.00[ASN][1000 genomes] |
rs2668668 | 1.00[ASN][1000 genomes] |
rs2668670 | 1.00[ASN][1000 genomes] |
rs2668687 | 0.84[AMR][1000 genomes];0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668691 | 1.00[ASN][1000 genomes] |
rs2668692 | 1.00[ASN][1000 genomes] |
rs2668694 | 1.00[ASN][1000 genomes] |
rs2668695 | 1.00[ASN][1000 genomes] |
rs2668713 | 0.86[AMR][1000 genomes];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668719 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2668723 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696429 | 0.89[AMR][1000 genomes];0.85[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696430 | 0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696445 | 1.00[ASN][1000 genomes] |
rs2696515 | 0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696516 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696517 | 0.82[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696518 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696522 | 0.82[AFR][1000 genomes];0.93[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696524 | 0.82[AFR][1000 genomes];0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696525 | 0.91[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696527 | 0.91[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696528 | 1.00[ASN][1000 genomes] |
rs2696530 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696531 | 0.88[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696532 | 0.82[AFR][1000 genomes];0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696533 | 0.82[AFR][1000 genomes];0.91[AMR][1000 genomes];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696534 | 0.82[AFR][1000 genomes];0.91[AMR][1000 genomes];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696535 | 0.82[AFR][1000 genomes];0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696542 | 0.91[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs2696547 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696551 | 0.81[AFR][1000 genomes];0.84[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696555 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696559 | 0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696560 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696561 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes];0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696565 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2696566 | 1.00[ASN][1000 genomes] |
rs2696568 | 1.00[ASN][1000 genomes] |
rs2696569 | 1.00[ASN][1000 genomes] |
rs2696608 | 1.00[ASN][1000 genomes] |
rs2696609 | 1.00[ASN][1000 genomes] |
rs2696610 | 1.00[ASN][1000 genomes] |
rs2696617 | 1.00[ASN][1000 genomes] |
rs2696633 | 1.00[ASN][1000 genomes] |
rs2696635 | 1.00[ASN][1000 genomes] |
rs2696673 | 1.00[ASN][1000 genomes] |
rs2732601 | 1.00[ASN][1000 genomes] |
rs2732613 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732619 | 1.00[ASN][1000 genomes] |
rs2732625 | 0.88[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732628 | 1.00[ASN][1000 genomes] |
rs2732629 | 1.00[ASN][1000 genomes] |
rs2732631 | 1.00[ASN][1000 genomes] |
rs2732649 | 0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732650 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs2732651 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes] |
rs2732652 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732654 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732655 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732682 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732683 | 1.00[ASN][1000 genomes] |
rs2732685 | 0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732703 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732704 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732705 | 0.82[AFR][1000 genomes];0.95[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732706 | 0.82[AFR][1000 genomes];0.96[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732707 | 0.81[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732708 | 0.96[AMR][1000 genomes];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732710 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732711 | 0.81[AFR][1000 genomes];0.84[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732712 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732713 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732715 | 1.00[ASN][1000 genomes] |
rs2942160 | 1.00[ASN][1000 genomes] |
rs2942175 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2942176 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2942177 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2942178 | 1.00[ASN][1000 genomes] |
rs2950015 | 0.83[AMR][1000 genomes] |
rs2950691 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2950692 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2950693 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2950694 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2950706 | 1.00[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2957296 | 1.00[ASN][1000 genomes] |
rs2957297 | 1.00[ASN][1000 genomes] |
rs3087534 | 1.00[ASN][1000 genomes] |
rs3108506 | 1.00[ASN][1000 genomes] |
rs3110331 | 1.00[ASN][1000 genomes] |
rs3110333 | 1.00[ASN][1000 genomes] |
rs34046424 | 0.86[AMR][1000 genomes];0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35524223 | 1.00[ASN][1000 genomes] |
rs36036607 | 1.00[ASN][1000 genomes] |
rs36050210 | 0.82[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs36123991 | 0.82[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs3865315 | 1.00[ASN][1000 genomes] |
rs3912060 | 1.00[ASN][1000 genomes] |
rs3912061 | 1.00[ASN][1000 genomes] |
rs3912062 | 1.00[ASN][1000 genomes] |
rs3912063 | 1.00[ASN][1000 genomes] |
rs4383188 | 1.00[ASN][1000 genomes] |
rs4471723 | 1.00[ASN][1000 genomes] |
rs4548919 | 1.00[ASN][1000 genomes] |
rs4581739 | 1.00[ASN][1000 genomes] |
rs4630591 | 1.00[ASN][1000 genomes] |
rs55648323 | 1.00[ASN][1000 genomes] |
rs55653937 | 1.00[ASN][1000 genomes] |
rs55669501 | 1.00[ASN][1000 genomes] |
rs55672516 | 1.00[ASN][1000 genomes] |
rs55686102 | 1.00[ASN][1000 genomes] |
rs55692232 | 1.00[ASN][1000 genomes] |
rs55744103 | 1.00[ASN][1000 genomes] |
rs55780786 | 1.00[ASN][1000 genomes] |
rs55790833 | 1.00[ASN][1000 genomes] |
rs55794067 | 1.00[ASN][1000 genomes] |
rs55802590 | 1.00[ASN][1000 genomes] |
rs55825513 | 1.00[ASN][1000 genomes] |
rs55864131 | 1.00[ASN][1000 genomes] |
rs55885063 | 1.00[ASN][1000 genomes] |
rs55900347 | 1.00[ASN][1000 genomes] |
rs55909047 | 1.00[ASN][1000 genomes] |
rs55955207 | 1.00[ASN][1000 genomes] |
rs55972730 | 1.00[ASN][1000 genomes] |
rs55987700 | 1.00[ASN][1000 genomes] |
rs56078347 | 1.00[ASN][1000 genomes] |
rs56100031 | 1.00[ASN][1000 genomes] |
rs56119705 | 1.00[ASN][1000 genomes] |
rs56240678 | 1.00[ASN][1000 genomes] |
rs56257094 | 1.00[ASN][1000 genomes] |
rs56273589 | 1.00[ASN][1000 genomes] |
rs62060812 | 1.00[ASN][1000 genomes] |
rs62060834 | 1.00[ASN][1000 genomes] |
rs62060835 | 1.00[ASN][1000 genomes] |
rs62060836 | 1.00[ASN][1000 genomes] |
rs62060837 | 1.00[ASN][1000 genomes] |
rs62060838 | 1.00[ASN][1000 genomes] |
rs62060839 | 1.00[ASN][1000 genomes] |
rs62060840 | 1.00[ASN][1000 genomes] |
rs62060841 | 1.00[ASN][1000 genomes] |
rs62060842 | 1.00[ASN][1000 genomes] |
rs62060843 | 1.00[ASN][1000 genomes] |
rs62060844 | 1.00[ASN][1000 genomes] |
rs62060845 | 1.00[ASN][1000 genomes] |
rs62060846 | 1.00[ASN][1000 genomes] |
rs62060847 | 1.00[ASN][1000 genomes] |
rs62060850 | 1.00[ASN][1000 genomes] |
rs62060851 | 1.00[ASN][1000 genomes] |
rs62060852 | 1.00[ASN][1000 genomes] |
rs62060853 | 1.00[ASN][1000 genomes] |
rs62060856 | 1.00[ASN][1000 genomes] |
rs62060858 | 1.00[ASN][1000 genomes] |
rs62060859 | 1.00[ASN][1000 genomes] |
rs62060946 | 1.00[ASN][1000 genomes] |
rs62060947 | 1.00[ASN][1000 genomes] |
rs62060952 | 1.00[ASN][1000 genomes] |
rs62061764 | 1.00[ASN][1000 genomes] |
rs62061766 | 1.00[ASN][1000 genomes] |
rs62061767 | 1.00[ASN][1000 genomes] |
rs62061770 | 1.00[ASN][1000 genomes] |
rs62061771 | 1.00[ASN][1000 genomes] |
rs62061772 | 1.00[ASN][1000 genomes] |
rs62061788 | 1.00[ASN][1000 genomes] |
rs62061789 | 1.00[ASN][1000 genomes] |
rs62061790 | 1.00[ASN][1000 genomes] |
rs62061791 | 1.00[ASN][1000 genomes] |
rs62061792 | 1.00[ASN][1000 genomes] |
rs62061793 | 1.00[ASN][1000 genomes] |
rs62061795 | 1.00[ASN][1000 genomes] |
rs62061796 | 1.00[ASN][1000 genomes] |
rs62061798 | 1.00[ASN][1000 genomes] |
rs62061800 | 1.00[ASN][1000 genomes] |
rs62061801 | 1.00[ASN][1000 genomes] |
rs62061802 | 1.00[ASN][1000 genomes] |
rs62061803 | 1.00[ASN][1000 genomes] |
rs62061807 | 1.00[ASN][1000 genomes] |
rs62061808 | 1.00[ASN][1000 genomes] |
rs62061809 | 1.00[ASN][1000 genomes] |
rs62061810 | 1.00[ASN][1000 genomes] |
rs62061811 | 1.00[ASN][1000 genomes] |
rs62061812 | 1.00[ASN][1000 genomes] |
rs62061814 | 1.00[ASN][1000 genomes] |
rs62061815 | 1.00[ASN][1000 genomes] |
rs62061816 | 1.00[ASN][1000 genomes] |
rs62061817 | 1.00[ASN][1000 genomes] |
rs62061818 | 1.00[ASN][1000 genomes] |
rs62061820 | 1.00[ASN][1000 genomes] |
rs62061821 | 1.00[ASN][1000 genomes] |
rs62061822 | 1.00[ASN][1000 genomes] |
rs62061823 | 1.00[ASN][1000 genomes] |
rs62061824 | 1.00[ASN][1000 genomes] |
rs62061845 | 1.00[ASN][1000 genomes] |
rs62061847 | 1.00[ASN][1000 genomes] |
rs62061848 | 1.00[ASN][1000 genomes] |
rs62061849 | 1.00[ASN][1000 genomes] |
rs62061850 | 1.00[ASN][1000 genomes] |
rs62061851 | 1.00[ASN][1000 genomes] |
rs62061852 | 1.00[ASN][1000 genomes] |
rs62061853 | 1.00[ASN][1000 genomes] |
rs62061854 | 1.00[ASN][1000 genomes] |
rs62061855 | 1.00[ASN][1000 genomes] |
rs62061856 | 1.00[ASN][1000 genomes] |
rs62061858 | 1.00[ASN][1000 genomes] |
rs62061859 | 1.00[ASN][1000 genomes] |
rs62063163 | 1.00[ASN][1000 genomes] |
rs62063164 | 1.00[ASN][1000 genomes] |
rs62063165 | 1.00[ASN][1000 genomes] |
rs62063166 | 1.00[ASN][1000 genomes] |
rs62063171 | 1.00[ASN][1000 genomes] |
rs62063172 | 1.00[ASN][1000 genomes] |
rs62063174 | 1.00[ASN][1000 genomes] |
rs62063200 | 1.00[ASN][1000 genomes] |
rs62063201 | 1.00[ASN][1000 genomes] |
rs62063202 | 1.00[ASN][1000 genomes] |
rs62063203 | 1.00[ASN][1000 genomes] |
rs62063207 | 1.00[ASN][1000 genomes] |
rs62063208 | 1.00[ASN][1000 genomes] |
rs62063212 | 1.00[ASN][1000 genomes] |
rs62063234 | 1.00[ASN][1000 genomes] |
rs62070911 | 1.00[ASN][1000 genomes] |
rs62070948 | 1.00[ASN][1000 genomes] |
rs62071576 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs62071596 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs62071621 | 1.00[ASN][1000 genomes] |
rs62071631 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs62071640 | 1.00[ASN][1000 genomes] |
rs62073099 | 1.00[ASN][1000 genomes] |
rs62073152 | 1.00[ASN][1000 genomes] |
rs62073155 | 0.84[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs62073156 | 0.93[AMR][1000 genomes];0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62073157 | 0.82[AMR][1000 genomes] |
rs62074562 | 0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs6503457 | 1.00[ASN][1000 genomes] |
rs7207582 | 1.00[ASN][1000 genomes] |
rs727425 | 1.00[ASN][1000 genomes] |
rs73984689 | 1.00[ASN][1000 genomes] |
rs7502848 | 1.00[ASN][1000 genomes] |
rs8070942 | 1.00[ASN][1000 genomes] |
rs8080583 | 1.00[ASN][1000 genomes] |
rs9303525 | 1.00[ASN][1000 genomes] |
rs9907738 | 1.00[ASN][1000 genomes] |
rs9915547 | 1.00[ASN][1000 genomes] |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv817315 | chr17:43651731-44351152 | Enhancers ZNF genes & repeats Bivalent Enhancer Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
2 | nsv529777 | chr17:43653227-44351644 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
3 | nsv1067695 | chr17:43655747-44351152 | Weak transcription Active TSS Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
4 | nsv529378 | chr17:43655747-44351152 | Enhancers Active TSS Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
5 | nsv529778 | chr17:43675408-44351152 | Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 48 gene(s) | inside rSNPs | diseases |
6 | nsv529780 | chr17:43706686-44485971 | Active TSS Strong transcription Enhancers Weak transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
7 | nsv817460 | chr17:43706886-44351152 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
8 | nsv529278 | chr17:43706886-44694283 | Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
9 | nsv534157 | chr17:43717703-44345038 | Enhancers Strong transcription Active TSS Bivalent Enhancer Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
10 | nsv529794 | chr17:43717703-44351152 | Weak transcription Strong transcription Bivalent/Poised TSS Active TSS Enhancers Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
11 | nsv948604 | chr17:43741452-44364056 | Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
12 | nsv529795 | chr17:43751674-44351152 | Flanking Active TSS Strong transcription Enhancers Weak transcription Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
13 | nsv949112 | chr17:43763241-44364056 | Weak transcription Transcr. at gene 5' and 3' Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
14 | nsv431716 | chr17:43893020-44868187 | Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 62 gene(s) | inside rSNPs | diseases |
15 | esv2751685 | chr17:44004972-44789317 | Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
16 | esv2751686 | chr17:44039564-44364056 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
17 | nsv431717 | chr17:44075901-44809001 | Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
18 | nsv471698 | chr17:44079479-44378253 | Strong transcription Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
19 | nsv431718 | chr17:44094463-44873614 | Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
20 | esv2751687 | chr17:44094471-44364056 | Enhancers Strong transcription Active TSS Weak transcription Genic enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
21 | nsv575144 | chr17:44109474-44354796 | Enhancers Strong transcription Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
22 | nsv516807 | chr17:44109474-44793283 | Active TSS Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
23 | nsv431719 | chr17:44111853-44364056 | Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
24 | esv2751688 | chr17:44115107-44364056 | Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
25 | nsv431720 | chr17:44115107-44364056 | Strong transcription Weak transcription Active TSS Enhancers Genic enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
26 | nsv1063349 | chr17:44116860-44435442 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 36 gene(s) | inside rSNPs | diseases |
27 | esv2753137 | chr17:44116950-44353885 | Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
28 | nsv431723 | chr17:44118999-44364056 | Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
29 | nsv575149 | chr17:44131305-44350090 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
30 | nsv575150 | chr17:44131305-44354796 | Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
31 | nsv543359 | chr17:44132076-44792529 | Weak transcription Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
32 | nsv431726 | chr17:44135864-44364056 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
33 | esv1792966 | chr17:44136000-44422977 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 35 gene(s) | inside rSNPs | diseases |
34 | nsv529718 | chr17:44138513-44694283 | Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
35 | nsv916230 | chr17:44138515-44694311 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
36 | esv2751689 | chr17:44139662-44364056 | Weak transcription Enhancers Genic enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
37 | esv2751690 | chr17:44139662-44364056 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
38 | esv2751691 | chr17:44139662-44795190 | Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
39 | esv2751692 | chr17:44139662-44811116 | Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
40 | esv2751693 | chr17:44139682-44364056 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
41 | esv2751694 | chr17:44139682-44789285 | Enhancers Genic enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
42 | esv2751695 | chr17:44139682-44801340 | Enhancers Active TSS Weak transcription Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
43 | nsv470589 | chr17:44140748-44350089 | Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
44 | nsv575152 | chr17:44140748-44350090 | Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
45 | nsv908312 | chr17:44140748-44354796 | Weak transcription Enhancers Strong transcription Active TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
46 | nsv908313 | chr17:44140748-44368215 | Weak transcription Strong transcription Active TSS Enhancers Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
47 | nsv908314 | chr17:44140748-44375017 | Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
48 | nsv908315 | chr17:44140748-44788310 | Weak transcription Bivalent/Poised TSS Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
49 | nsv543362 | chr17:44141175-44792529 | Weak transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
50 | nsv431728 | chr17:44144214-44353885 | Enhancers ZNF genes & repeats Strong transcription Active TSS Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs2532343 | ARHGAP27 | Cis_1M | lymphoblastoid | RTeQTL |
rs2532343 | LRRC37A3 | Cis_chr | lymphoblastoid | RTeQTL |
rs2532343 | LRRC37A4 | Cis_1M | lymphoblastoid | RTeQTL |
rs2532343 | LOC644246 | Cis_1M | lymphoblastoid | RTeQTL |
rs2532343 | ARL17 | Cis_1M | lymphoblastoid | RTeQTL |
rs2532343 | MAPK8IP1 | trans | lymphoblastoid | RTeQTL |
rs2532343 | BPTF | Cis_chr | lymphoblastoid | RTeQTL |
rs2532343 | LRRC37A4 | cis | multi-tissue | Pritchard |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:44343200-44344200 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr17:44343200-44344400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr17:44343200-44345600 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
4 | chr17:44343400-44344200 | Flanking Active TSS | Primary hematopoietic stem cells | blood |
5 | chr17:44343400-44344200 | Flanking Active TSS | Primary T helper cells fromperipheralblood | blood |
6 | chr17:44343400-44344200 | Flanking Active TSS | Primary T killer naive cells fromperipheralblood | blood |
7 | chr17:44343400-44344200 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
8 | chr17:44343400-44344200 | Flanking Active TSS | Dnd41 | blood |
9 | chr17:44343400-44344200 | Flanking Active TSS | Hela-S3 | cervix |
10 | chr17:44343400-44344200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
11 | chr17:44343400-44344800 | Bivalent/Poised TSS | H9 Cell Line | embryonic stem cell |
12 | chr17:44343400-44345200 | Flanking Active TSS | Primary B cells from cord blood | blood |
13 | chr17:44343400-44345200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr17:44343400-44345200 | Active TSS | Fetal Kidney | kidney |
15 | chr17:44343400-44345400 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
16 | chr17:44343400-44345400 | Active TSS | Brain Germinal Matrix | brain |
17 | chr17:44343600-44344200 | Flanking Bivalent TSS/Enh | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr17:44343600-44344200 | Flanking Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
19 | chr17:44343600-44344200 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
20 | chr17:44343600-44344200 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
21 | chr17:44343600-44344200 | Flanking Bivalent TSS/Enh | Primary T regulatory cells fromperipheralblood | blood |
22 | chr17:44343600-44344200 | Flanking Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
23 | chr17:44343600-44344200 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
24 | chr17:44343600-44344200 | Flanking Active TSS | Cortex derived primary cultured neurospheres | brain |
25 | chr17:44343600-44344200 | Flanking Active TSS | Primary mononuclear cells fromperipheralblood | Blood |
26 | chr17:44343600-44344200 | Flanking Active TSS | Placenta | Placenta |
27 | chr17:44343600-44344200 | Flanking Active TSS | A549 | lung |
28 | chr17:44343600-44344200 | Flanking Active TSS | GM12878-XiMat | blood |
29 | chr17:44343600-44344200 | Flanking Active TSS | HSMM | muscle |
30 | chr17:44343600-44344200 | Flanking Active TSS | NH-A | brain |
31 | chr17:44343600-44344800 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
32 | chr17:44343600-44344800 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
33 | chr17:44343600-44344800 | Flanking Active TSS | Colonic Mucosa | Colon |
34 | chr17:44343600-44345200 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
35 | chr17:44343600-44345200 | Bivalent/Poised TSS | ES-WA7 Cell Line | embryonic stem cell |
36 | chr17:44343600-44345200 | Bivalent/Poised TSS | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
37 | chr17:44343600-44345200 | Active TSS | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
38 | chr17:44343600-44345200 | Bivalent/Poised TSS | iPS-20b Cell Line | embryonic stem cell |
39 | chr17:44343600-44345200 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
40 | chr17:44343600-44345200 | Active TSS | Aorta | Aorta |
41 | chr17:44343600-44345200 | Active TSS | Esophagus | oesophagus |
42 | chr17:44343600-44345200 | Active TSS | Left Ventricle | heart |
43 | chr17:44343600-44345200 | Active TSS | Ovary | ovary |
44 | chr17:44343600-44345400 | Active TSS | Pancreatic Islets | Pancreatic Islet |
45 | chr17:44343800-44344200 | Flanking Active TSS | Primary T cells fromperipheralblood | blood |
46 | chr17:44343800-44344200 | Flanking Active TSS | HMEC | breast |
47 | chr17:44343800-44344600 | Bivalent/Poised TSS | H1 Cell Line | embryonic stem cell |
48 | chr17:44343800-44344600 | Bivalent/Poised TSS | HUES48 Cell Line | embryonic stem cell |
49 | chr17:44343800-44344600 | Active TSS | Brain Angular Gyrus | brain |
50 | chr17:44343800-44344800 | Bivalent/Poised TSS | iPS-18 Cell Line | embryonic stem cell |